Form 8-K - Current report:
SEC Accession No. 0001193125-26-152826
Filing Date
2026-04-13
Accepted
2026-04-13 16:00:08
Documents
9
Period of Report
2026-04-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K cue-20260413.htm   iXBRL 8-K 94841
  Complete submission text file 0001193125-26-152826.txt   227909

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cue-20260413.xsd EX-101.SCH 46337
12 EXTRACTED XBRL INSTANCE DOCUMENT cue-20260413_htm.xml XML 4511
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 26857772
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)